Free Trial

AxoGen (AXGN) Competitors

$7.00
+0.19 (+2.79%)
(As of 06/21/2024 ET)

AXGN vs. CUTR, BLFS, ZYXI, SMLR, OM, EDAP, ELMD, FONR, VANI, and HYPR

Should you be buying AxoGen stock or one of its competitors? The main competitors of AxoGen include Cutera (CUTR), BioLife Solutions (BLFS), Zynex (ZYXI), Semler Scientific (SMLR), Outset Medical (OM), Edap Tms (EDAP), Electromed (ELMD), FONAR (FONR), Vivani Medical (VANI), and Hyperfine (HYPR). These companies are all part of the "electromedical equipment" industry.

AxoGen vs.

Cutera (NASDAQ:CUTR) and AxoGen (NASDAQ:AXGN) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, community ranking, dividends, media sentiment, institutional ownership, analyst recommendations and profitability.

In the previous week, AxoGen had 2 more articles in the media than Cutera. MarketBeat recorded 3 mentions for AxoGen and 1 mentions for Cutera. Cutera's average media sentiment score of 0.20 beat AxoGen's score of 0.00 indicating that AxoGen is being referred to more favorably in the news media.

Company Overall Sentiment
Cutera Neutral
AxoGen Neutral

AxoGen has a net margin of -12.99% compared to AxoGen's net margin of -73.42%. AxoGen's return on equity of 0.00% beat Cutera's return on equity.

Company Net Margins Return on Equity Return on Assets
Cutera-73.42% N/A -37.78%
AxoGen -12.99%-22.18%-11.06%

90.7% of Cutera shares are owned by institutional investors. Comparatively, 80.3% of AxoGen shares are owned by institutional investors. 2.1% of Cutera shares are owned by insiders. Comparatively, 7.0% of AxoGen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

AxoGen received 112 more outperform votes than Cutera when rated by MarketBeat users. Likewise, 72.52% of users gave AxoGen an outperform vote while only 64.73% of users gave Cutera an outperform vote.

CompanyUnderperformOutperform
CuteraOutperform Votes
334
64.73%
Underperform Votes
182
35.27%
AxoGenOutperform Votes
446
72.52%
Underperform Votes
169
27.48%

Cutera has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500. Comparatively, AxoGen has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500.

Cutera currently has a consensus target price of $7.67, indicating a potential upside of 397.84%. AxoGen has a consensus target price of $12.00, indicating a potential upside of 71.43%. Given AxoGen's higher probable upside, analysts clearly believe Cutera is more favorable than AxoGen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cutera
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
AxoGen
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

AxoGen has lower revenue, but higher earnings than Cutera. AxoGen is trading at a lower price-to-earnings ratio than Cutera, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cutera$212.37M0.15-$162.83M-$7.22-0.21
AxoGen$159.01M1.92-$21.72M-$0.50-14.00

Summary

AxoGen beats Cutera on 12 of the 18 factors compared between the two stocks.

Get AxoGen News Delivered to You Automatically

Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AXGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AXGN vs. The Competition

MetricAxoGenElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$297.63M$3.29B$5.20B$8.43B
Dividend YieldN/A1.75%2.82%4.09%
P/E Ratio-14.006.60111.6013.92
Price / Sales1.9253.202,177.0972.13
Price / CashN/A71.5333.9130.95
Price / Book3.153.774.724.19
Net Income-$21.72M$87.35M$110.59M$216.41M
7 Day Performance-8.38%-0.95%-2.24%-1.23%
1 Month Performance12.90%-8.03%-4.47%-3.91%
1 Year Performance-22.91%-6.55%-3.21%-0.27%

AxoGen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CUTR
Cutera
1.0411 of 5 stars
$1.54
-7.2%
$7.67
+397.8%
-90.3%$30.95M$212.37M-0.21540Analyst Forecast
BLFS
BioLife Solutions
0.8097 of 5 stars
$21.00
+0.8%
$23.67
+12.7%
-10.8%$967.47M$143.27M-14.79409Insider Selling
News Coverage
Positive News
ZYXI
Zynex
2.8142 of 5 stars
$9.00
-2.0%
$18.00
+100.0%
-7.1%$285.93M$184.32M39.131,100
SMLR
Semler Scientific
0 of 5 stars
$36.65
+4.0%
N/A+42.7%$259.12M$68.18M13.1492Gap Down
High Trading Volume
OM
Outset Medical
1.1949 of 5 stars
$4.33
+20.9%
$5.42
+25.1%
-80.0%$223.95M$130.38M-1.28480Analyst Upgrade
News Coverage
Gap Up
High Trading Volume
EDAP
Edap Tms
2.9989 of 5 stars
$5.27
-0.2%
$14.00
+165.7%
-41.2%$195.54M$60.54M-9.76307Short Interest ↓
Positive News
ELMD
Electromed
0 of 5 stars
$14.32
+0.1%
N/AN/A$124.01M$48.07M28.64170
FONR
FONAR
0 of 5 stars
$15.35
+1.5%
N/A-9.2%$97.17M$98.64M9.84561
VANI
Vivani Medical
0 of 5 stars
$1.25
flat
N/A-1.6%$68.73MN/A-2.5044Gap Down
HYPR
Hyperfine
1.3859 of 5 stars
$0.83
+1.2%
$2.12
+156.1%
-64.4%$59.47M$11.03M-1.40131

Related Companies and Tools

This page (NASDAQ:AXGN) was last updated on 6/22/2024 by MarketBeat.com Staff

From Our Partners